Tekla Healthcare Financials
HQH Stock | USD 17.40 0.10 0.58% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0 | 0.0 |
|
| |||||
Current Ratio | 16.0 | 31.06 |
|
|
The financial analysis of Tekla Healthcare is a critical element in measuring its lifeblood. Investors should not minimize Tekla Healthcare's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Tekla | Select Account or Indicator |
Understanding current and past Tekla Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tekla Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Tekla Healthcare's assets may result in an increase in income on the income statement.
Tekla Healthcare Stock Summary
Tekla Healthcare competes with Tekla Healthcare, Eaton Vance, Tekla World, Cohen Steers, and Tekla Life. Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Tekla Healthcare operates under Asset Management classification in the United States and is traded on New York Stock Exchange.Specialization | Financial Services, Financial Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US87911J1034 |
CUSIP | 87911J103 404052102 404052961 |
Location | Massachusetts; U.S.A |
Business Address | 1900 Market Street, |
Sector | Capital Markets |
Industry | Financials |
Benchmark | Dow Jones Industrial |
Website | www.teklacap.com/hqh.html |
Phone | 215 405 5700 |
Currency | USD - US Dollar |
Tekla Healthcare Key Financial Ratios
Return On Equity | 0.0734 | |||
Profit Margin | 7.31 % | |||
Operating Margin | (0.01) % | |||
Price To Sales | 88.36 X | |||
Revenue | 58.12 M |
Tekla Healthcare Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.1B | 1.2B | 926.3M | 932.5M | 1.1B | 673.0M | |
Other Current Liab | (31.4K) | 4.3M | 1.2M | 1.1M | 1.0M | 982.1K | |
Net Debt | 2.5M | 11.3M | 8.5M | (214.0) | (246.1) | (233.79) | |
Cash | (2.5M) | 935.0 | 792.0 | 214.0 | 192.6 | 182.97 | |
Other Assets | 264.1K | 66.1K | 49.4K | (32.7M) | (29.5M) | (28.0M) | |
Total Liab | 1.1M | 15.6M | 9.7M | 1.1M | 1.3M | 1.3M | |
Total Current Assets | 4.1M | 4.0M | 2.9M | 39.6M | 45.6M | 47.9M | |
Common Stock | 438.7K | 454.3K | 473.4K | 494.4K | 568.6K | 540.2K | |
Net Receivables | 4.1M | 4.0M | 2.9M | 6.9M | 7.9M | 8.3M | |
Net Tangible Assets | 870.8M | 1.1B | 1.2B | 916.6M | 1.1B | 962.8M | |
Retained Earnings | 239.5M | 303.1M | 24.8M | 6.0M | 5.4M | 5.1M | |
Other Current Assets | 2.5M | 8.4M | 39.8M | 32.8M | 29.5M | 19.5M | |
Capital Stock | 438.7K | 454.3K | 473.4K | 494.4K | 445.0K | 422.7K |
Tekla Healthcare Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 242.9M | 157.1M | (192.3M) | 58.1M | 66.8M | 70.2M | |
Gross Profit | 242.9M | 157.1M | (192.3M) | 58.1M | 66.8M | 70.2M | |
Operating Income | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 68.0M | |
Ebit | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 35.7M | |
Ebitda | 243.2M | 161.4M | (190.6M) | 56.3M | 64.8M | 64.1M | |
Cost Of Revenue | 10.0M | 11.8M | 11.3M | 10.9M | 12.5M | 7.3M | |
Income Before Tax | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 48.6M | |
Net Income | 241.2M | 155.2M | (194.2M) | 56.3M | 64.8M | 48.6M | |
Income Tax Expense | (2.0M) | (6.2M) | (3.7M) | (1.2M) | (1.1M) | (1.1M) | |
Interest Income | 265.1K | 161.3M | 112.3K | 620.0K | 558.0K | 530.1K | |
Net Interest Income | 287.6K | 265.1K | 112.3K | 620.0K | 713.0K | 748.7K | |
Research Development | 2.62 | 1.74 | 2.6 | 0.56 | 0.5 | 0.48 |
Tekla Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tekla Healthcare's current stock value. Our valuation model uses many indicators to compare Tekla Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tekla Healthcare competition to find correlations between indicators driving Tekla Healthcare's intrinsic value. More Info.Tekla Healthcare Investors is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . As of now, Tekla Healthcare's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tekla Healthcare's earnings, one of the primary drivers of an investment's value.Tekla Healthcare Inv Systematic Risk
Tekla Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tekla Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Tekla Healthcare Inv correlated with the market. If Beta is less than 0 Tekla Healthcare generally moves in the opposite direction as compared to the market. If Tekla Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tekla Healthcare Inv is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tekla Healthcare is generally in the same direction as the market. If Beta > 1 Tekla Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Tekla Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tekla Healthcare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tekla Healthcare growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Tekla Healthcare November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tekla Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tekla Healthcare Investors. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tekla Healthcare Investors based on widely used predictive technical indicators. In general, we focus on analyzing Tekla Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tekla Healthcare's daily price indicators and compare them against related drivers.
Information Ratio | (0.25) | |||
Maximum Drawdown | 6.31 | |||
Value At Risk | (1.56) | |||
Potential Upside | 1.08 |
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |